Summary
No overall score for this company yet.
Valuation -Growth -Profitability -Quality 37Debt 0Stability 67
What speaks for it
None of the indicators we track stands out on the positive side.
What to watch
- It passes only 2 of the 9 points of the Piotroski financial health test.
- For every 100 USD of bills due within a year it has 0.7 USD of short-term assets.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Is it growing?
Revenue (USD)
20212022202320242025
Diluted EPS (USD)
20212022202320242025
There is not enough revenue history yet to say how fast it grows.
Growth in detailDoes it make money?
Over the last 12 months it made a loss of $74.0K.
Profitability in detailIs it financially healthy?
Debt is a burdenCash and short-term investments $1.72K
Debt $834.2K
Free cash flow over 12 months -$64.4K
Over the last 12 months it spent more cash than it brought in. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
Fiscal year 2013By product
The company reports no revenue by product.
By region
- GeographicalRevenue 50%
- USA 50%
GeographicalRevenue brings in 50% of revenue.
Segments in detail